Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22:3–15.

Article  PubMed  Google Scholar 

Li S, Xie H, Shi Y, Liu H. Prevalence of diabetic nephropathy in the diabetes mellitus population: a protocol for systematic review and meta-analysis. Medicine. 2022;101(42):e31232.

Article  PubMed  PubMed Central  Google Scholar 

Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. BioMed Res Int. 2021;2021(1):1497449.

Article  PubMed  PubMed Central  Google Scholar 

Pour-Reza-Gholi F, Assadiasl S. Immunological approaches in the treatment of diabetic nephropathy. Curr Diabetes Rev. 2025;21(1):E061123223172.

Article  Google Scholar 

Yang M, Zhang C. The role of innate immunity in diabetic nephropathy and their therapeutic consequences. J Pharm Anal. 2024;14(1):39–51.

Article  PubMed  Google Scholar 

Assadiasl S, Ahmadpoor P, Nafar M, Lessan Pezeshki M, Pourrezagholi F, Parvin M, et al. Regulatory T cell subtypes and TGF-β1 gene expression in chronic allograft dysfunction. Iran J Immunol. 2014;11(3):139–52.

PubMed  Google Scholar 

Sameir M, Soleimanifar N, Selman N, Assadiasl S, Sadr M, Mojtahedi H, et al. Regulatory T cells and type 1 regulatory T cells as immuno-cell therapy in type 1 diabetes. Hammurabi J Med Sci. 2024;1(2):36–42.

Google Scholar 

Wang L, Wang H-l, Lan H-y. TGF-β signaling in diabetic nephropathy: an update. Diabet Nephrop. 2022;2(1):7–16.

Article  Google Scholar 

Campbell KN, Raij L, Mundel P. Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes. Curr Diabetes Rev. 2011;7(1):3–7. https://doi.org/10.2174/157339911794273973.

Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Miao R, Yu T, Wei R, Tian F, Huang Y, et al. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: a systematic review and network meta-analysis. Pharmacol Res. 2022;177:106111.

Article  PubMed  Google Scholar 

Biancardi VC, Bomfim GF, Reis WL, Al-Gassimi S, Nunes KP. The interplay between angiotensin II, TLR4 and hypertension. Pharmacol Res. 2017;120:88–96.

Article  PubMed  Google Scholar 

Singh MV, Cicha MZ, Nunez S, Meyerholz DK, Chapleau MW, Abboud FM. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3-and TLR4-dependent pathways. Am J Physiol Heart Circ Physiol. 2019;316(5):H1027-38.

Article  PubMed  PubMed Central  Google Scholar 

Assadiasl S, Mousavi MJ, Amirzargar A. Toll-like receptor 4 in renal transplant. Exp Clin Transpl. 2018;16(3):245–52.

Google Scholar 

De Batista PR, Palacios R, Martin A, Hernanz R, Medici CT, Silva MA, et al. Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production. PLoS ONE. 2014;9(8):e104020.

Article  PubMed  PubMed Central  Google Scholar 

Mattorre B, Tedeschi V, Paldino G, Fiorillo MT, Paladini F, Sorrentino R. The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation. Front Immunol. 2022;13:1002375.

Article  PubMed  PubMed Central  Google Scholar 

Zee RY, Rivera A, Inostroza Y, Ridker PM, Chasman DI, Romero JR. Gene variation of endoplasmic reticulum aminopeptidases 1 and 2, and risk of blood pressure progression and incident hypertension among 17,255 initially healthy women. Int J Genomics. 2018;2018(1):2308585.

PubMed  PubMed Central  Google Scholar 

Hovind P, Rossing P, Tarnow L, Smidt UM, Parving H-H. Progression of diabetic nephropathy. Kidney Int. 2001;59(2):702–9. https://doi.org/10.1046/j.1523-1755.2001.059002702.x.

Article  PubMed  Google Scholar 

Naaman SC, Bakris GL. Diabetic nephropathy: update on pillars of therapy slowing progression. Diabetes Care. 2023;46(9):1574–86.

Article  PubMed  PubMed Central  Google Scholar 

Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc. 2008;3(6):1101–8. https://doi.org/10.1038/nprot.2008.73.

Article  PubMed  Google Scholar 

Dargahi H, Nicknam MH, Mirahmadian M, Mahmoudi M, Aslani S, Sadrosadat M, et al. Association study of single nucleotide polymorphisms of Endoplasmic reticulum aminopeptidase 1 and 2 genes in Iranian women with preeclampsia. Iran J Public Health. 2019;48(3):531–40.

PubMed  PubMed Central  Google Scholar 

Mahmoudi M, Jamshidi AR, Amirzargar AA, Farhadi E, Nourijelyani K, Fallahi S et al. Association between Endoplasmic reticulum aminopeptidase-1 (ERAP-1) and susceptibility to ankylosing spondylitis in Iran. Iran J Allergy Asthma Immunol. 2012:294–300.

Harvey D, Pointon JJ, Evans DM, Karaderi T, Farrar C, Appleton LH, et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum Mol Genet. 2009;18(21):4204–12. https://doi.org/10.1093/hmg/ddp371.

Article  PubMed  PubMed Central  Google Scholar 

Akbulut E, Yıldırım T, Öztürk O. Endoplasmic reticulum aminopeptidase-1 polymorphism increases the risk of rheumatoid arthritis. Turk J Biochem. 2022;47(4):465–73.

Article  Google Scholar 

Gianchecchi E, Crinò A, Palma A, Luciano R, Perri V, Fruci D, et al. Case-control analysis of the ERAP1 polymorphism rs30187 in Italian type 1 diabetes mellitus patients. Health. 2013;5(12):2150–5.

Article  Google Scholar 

Alamdari A, Minoo FS, Assadiasl S, Freidoon M, Pour-Reza-Gholi F, Soleimanifar N, et al. Expression of programmed cell death 1 and helios genes correlates with rs872071A > G and rs12203592C > T Single-Nucleotide polymorphisms of interferonregulatory factor 4 in patients with T-Cell-Mediated rejection of renal Allograft. Experimental and clinical transplantation. official journal of the Middle East Society for Organ Transplantation; 2021.

Lim AK. Diabetic nephropathy–complications and treatment. Int J Nephrol Renovascular Disease. 2014:361–81.

Ameh OI, Okpechi IG, Agyemang C, Kengne AP. Global, regional, and ethnic differences in diabetic nephropathy. Diabetic nephropathy: pathophysiology and clinical aspects. Springer; 2018. pp. 33–44.

Karimi F, Maleki M, Movahedpour A, Alizadeh M, Kharazinejad E, Sabaghan M. Overview of the renin-angiotensin system in diabetic nephropathy. J Renin-Angiotensin-Aldosterone Syst. 2024;25:14703203241302966.

Article  Google Scholar 

Sanglard A, Miranda BCB, Vieira ALF, Macedo MVM, Santos RL, Campos ASRR, et al. The role of Renin-Angiotensin system in diabetic nephropathy: an update. Mini-Rev Med Chem. 2025;25(8):591–600.

Article  PubMed  Google Scholar 

Amann B, Tinzmann R, Angelkort B. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care. 2003;26(8):2421–5.

Article  PubMed  Google Scholar 

Chawla T, Sharma D, Singh A. Role of the renin angiotensin system in diabetic nephropathy. World J Diabetes. 2010;1(5):141.

Article  PubMed  PubMed Central  Google Scholar 

Bhandari S, Mehta S, Khwaja A, Cleland JG, Ives N, Brettell E, et al. Renin–angiotensin system inhibition in advanced chronic kidney disease. N Engl J Med. 2022;387(22):2021–32.

Article  PubMed  Google Scholar 

Cui X, Rouhani FN, Hawari F, Levine SJ. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem. 2003;278(31):28677–85.

Article  PubMed  Google Scholar 

Watanabe Y, Shibata K, Kikkawa F, Kajiyama H, Ino K, Hattori A, et al. Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Clin Cancer Res. 2003;9(17):6497–503.

PubMed  Google Scholar 

Goto Y, Ogawa K, Hattori A, Tsujimoto M. Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferon-γ. J Biol Chem. 2011;286(24):21906–14.

Article  PubMed  PubMed Central  Google Scholar 

Garibotto G, Carta A, Picciotto D, Viazzi F, Verzola D. Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy. J Nephrol. 2017;30(6):719–27.

Article  PubMed  Google Scholar 

Pan Y, Huang Y, Wang Z, Fang Q, Sun Y, Tong C, et al. Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ‐induced diabetic nephropathy. J Cell Mol Med. 2014;18(2):231–41.

Article  PubMed  Google Scholar 

Wang Y, Fang Q, Jin Y, Liu Z, Zou C, Yu W, et al. Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys. Br J Pharmacol. 2019;176(14):2642–57.

Article  PubMed  PubMed Central  Google Scholar 

Feng Q, Liu D, Lu Y, Liu Z. The interplay of renin-angiotensin system and toll‐like receptor 4 in the inflammation of diabetic nephropathy. J Immunol Res. 2020;2020(1):6193407.